Is there a new vaccination for patients with ovarian cancer?

A new cancer vaccine may be a game changer for patients with a certain type of ovarian cancer.

A study in patients with recurrent advanced epithelial ovarian cancer has shown that patients who received a special vaccine had survival of 100% at 24 months!

How does it work?  The patient’s had an injection of whole-tumor lysate.

What is tumor lysate?  Basically, the tumor is collected from the patient, emulsified, cooked in an incubator, and strained.  It is then injected back into the cancer patient.

The injection activates the patient’s own immune system.  This causes the patient’s own immune system to fight against their cancer.

ovarian cancer

 

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s